The NEDD4‐1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The NEDD4‐1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-08
DOI
10.1002/ijc.32615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plk1 overexpression induces chromosomal instability and suppresses tumor development
- (2018) Guillermo de Cárcer et al. Nature Communications
- NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma
- (2017) Zhi-Jun Huang et al. Oncology Letters
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- NEDD4-1 protects against ischaemia/reperfusion-induced cardiomyocyte apoptosis via the PI3K/Akt pathway
- (2016) Wei Hu et al. APOPTOSIS
- AKT in cancer: new molecular insights and advances in drug development
- (2016) Prabhjot S. Mundi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis
- (2016) Nandini Verma et al. CANCER RESEARCH
- Intestinal knockout of Nedd4 enhances growth of Apcmin tumors
- (2016) C Lu et al. ONCOGENE
- Genetics of multiple myeloma: another heterogeneity level?
- (2015) J. Corre et al. BLOOD
- NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling
- (2015) Yuping Zhang et al. GYNECOLOGIC ONCOLOGY
- Molecular mechanisms in multiple myeloma drug resistance
- (2015) Nicholas Nikesitch et al. JOURNAL OF CLINICAL PATHOLOGY
- SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization
- (2015) Weihua Zhou et al. Oncotarget
- AKT as a therapeutic target in multiple myeloma
- (2014) Niamh A Keane et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis
- (2014) Aiqin Sun et al. Molecular Cancer
- NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation
- (2014) Di-Feng Fang et al. Nature Communications
- Impeded Nedd4-1-Mediated Ras Degradation Underlies Ras-Driven Tumorigenesis
- (2014) Taoling Zeng et al. Cell Reports
- p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN
- (2013) S-W Hong et al. CELL DEATH AND DIFFERENTIATION
- Ubiquitin in the immune system
- (2013) Julia Zinngrebe et al. EMBO REPORTS
- Oncogenic function of p34SEI-1 via NEDD4-1-mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway
- (2013) SAMIL JUNG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Strategy for Modulation of Enzymes in the Ubiquitin System
- (2013) A. Ernst et al. SCIENCE
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- The histone deacetylase SIRT2 stabilizes Myc oncoproteins
- (2012) P Y Liu et al. CELL DEATH AND DIFFERENTIATION
- NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway
- (2012) Peter W. Eide et al. CELLULAR SIGNALLING
- TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
- (2012) Hong Liu et al. Clinical Lymphoma Myeloma & Leukemia
- Ubiquitin-dependent Regulation of Phospho-AKT Dynamics by the Ubiquitin E3 Ligase, NEDD4-1, in the Insulin-like Growth Factor-1 Response
- (2012) Chuan-Dong Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line
- (2011) Gobind Singh et al. BMC CANCER
- mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif
- (2011) You-Tong Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
- (2011) S K Kumar et al. LEUKEMIA
- Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung Carcinomas
- (2010) Nicola Amodio et al. AMERICAN JOURNAL OF PATHOLOGY
- Rak Functions as a Tumor Suppressor by Regulating PTEN Protein Stability and Function
- (2009) Eun-Kyoung Yim et al. CANCER CELL
- Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays
- (2009) Avinash Persaud et al. Molecular Systems Biology
- The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation
- (2009) W.-L. Yang et al. SCIENCE
- Expression of NEDD-1, a PTEN regulator, in gastric and colorectal carcinomas
- (2008) SUNG SOO KIM et al. APMIS
- Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation
- (2008) Xinjiang Wang et al. BIOCHEMICAL JOURNAL
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- (2008) N. Rhodes et al. CANCER RESEARCH
- The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization
- (2008) F. Fouladkou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started